alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Document headings vary by document type but may contain
                    the following: the agency or agencies that issued and signed a document
the number of the CFR title and the number of each part
                      the document amends, proposes to amend, or is directly
                      related to
the agency docket number / agency internal file number
the RIN which identifies each regulatory action listed in
                      the Unified Agenda of Federal Regulatory and Deregulatory
                      Actions See the
                    Document Drafting Handbook
                    for more details.
 Department of Justice Drug Enforcement Administration [Docket No. DEA-392]
 ACTION: Notice of application.
 DATES: Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration in accordance with 21 CFR 1301.33(a) on or before June 22, 2015.
 ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/ODW, 8701 Morrissette Drive, Springfield, Virginia 22152. Request for hearings should be sent to: Drug Enforcement Administration, Attention: Hearing Clerk/LJ, 8701 Morrissette Drive, Springfield, Virginia 22152.


SUPPLEMENTARY INFORMATION: The Attorney General has delegated his authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of manufacturers, distributors, dispensers, importers, and exporters of controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been redelegated to the Deputy Assistant Administrator of the DEA Office of Diversion Control (“Deputy Assistant Administrator”) pursuant to section 7 of 28 CFR part 0, appendix to subpart R. In accordance with 21 CFR 1301.33(a), this is notice that on January 29, 2015, Noramco, Inc., 500 Swedes Landing Road, Wilmington, Delaware 19801-4417 applied to be registered as a bulk manufacturer of the following basic classes of controlled substances: Controlled substance
ScheduleCodeine-N-oxide (9053)
IDihydromorphine (9145)
IMorphine-N-oxide (9307)
IAmphetamine (1100)
IIMethylphenidate (1724)
IIPhenylacetone (8501)
IICodeine (9050)
IIDihydrocodeine (9120)
IIOxycodone (9143)
IIHydromorphone (9150)
IIHydrocodone (9193)
IIMorphine (9300)
IIOripavine (9330)
IIThebaine (9333)
IIOpium extracts (9610)
IIOpium fluid extract (9620)
IIOpium tincture (9630)
IIOpium, powdered (9639)
IIOpium, granulated (9640)
IIOxymorphone (9652)
IINoroxymorphone (9668)
IITapentadol (9780)
II
 The company plans to manufacture the above-listed controlled substances in bulk for distribution to its customers. Dated: April 14, 2015. Joseph T. Rannazzisi, Deputy Assistant Administrator.


[FR Doc. 2015-09331 Filed 4-21-15; 8:45 am] BILLING CODE 4410-09-P
#### Ellis v Pepsi-Cola Bottling Company,

No. 90766;

Court of Appeals

No. 132268.
_______________________________________ __ Michigan Supreme Court 

# Order

Lansing, Michigan

October 29, 2007 Clifford W. Taylor, Chief Justice
134530 Michael F. Cavanagh Elizabeth A. Weaver Marilyn Kelly Maura D. Corrigan PEOPLE OF THE STATE OF MICHIGAN, Plaintiff-Appellee, Robert P. Young, Jr. Stephen J. Markman, Justices

v SC: 134530 COA: 269692 Oakland CC: 2006-206405-FH DANIEL ANTHONY AMARO, Defendant-Appellant.

________________ _______________ __________/

On order of the Court, the application for leave to appeal the June 12, 2007 judgment of the Court of Appeals is consid ered, and it is DENIED, because we are not persuaded that the questions presented should be reviewed by this Court.

t1022 I, Corbin R. Davis, Clerk of the Mi chigan Supreme Cour t, certify that the foregoing is a true and complete copy of the order entered at the direction of the Court.

October 29, 2007

Clerk
IN THE UNITED STATES DISTRICT COURT 

FOR THE SOUTHERN DISTRICT OF OHIO 

WESTERN DIVISION AT DAYTON 

CRYSTAL FITEZ-SKEENS, : Case No. 3:17-cv-313 

 : 

 Plaintiff, : Judge Thomas M. Rose 

 : 

v. : 

 : 

COMMISSIONER OF SOCIAL SECURITY, : 

 : 

 Defendant. : 

______________________________________________________________________________ 

ENTRY AND ORDER OVERRULING OBJECTIONS (DOC. 14), ADOPTING 

REPORT AND RECOMMENDATIONS (DOC. 12), AFFIRMING THE DENIAL 

OF BENEFITS AND TERMINATING THIS CASE 

______________________________________________________________________________ 

This appeal from the denial of Social Security benefits is before the Court on the 

Objections (Doc. 14) filed by Plaintiff Crystal Fitez-Skeens (“Plaintiff”) to Magistrate 

Judge Sharon L. Ovington’s Report and Recommendations (“Report”) (Doc. 12). In the 

Report, Magistrate Judge Ovington recommended that the Court affirm the ALJ’s 

decision denying Plaintiff’s application for Supplemental Security Income Disability 

Insurance Benefits and terminate this case. Plaintiff filed Objections (Doc. 14) to the 

Report. As the Court deems no response to the Objections necessary, this matter is ripe 

for review. 

As required by 28 U.S.C. § 636(b) and Federal Rule of Civil Procedure 72(b), the 

Court has made a de novo review of the record in this case. Upon said review, the Court 

finds that Plaintiff’s Objections to the Report are not well-taken and are hereby 

OVERRULED. The Court ADOPTS the Report (Doc. 12) and AFFIRMS the decision 
2 

denying Plaintiff’s applications for benefits (protectively filed on June 23, 2014). This case 

is hereby TERMINATED on the docket of this Court. 

DONE and ORDERED in Dayton, Ohio, this Tuesday, August 21, 2018. 

 s/Thomas M. Rose 

 ________________________________ 

 THOMAS M. ROSE 

 UNITED STATES DISTRICT JUDGE
```

[Congressional Bills 111th Congress]
[From the U.S. Government Publishing Office]
[H.R. 4017 Enrolled Bill (ENR)]

        H.R.4017

                      One Hundred Eleventh Congress

                                 of the

                        United States of America

                          AT THE SECOND SESSION

          Begun and held at the City of Washington on Tuesday,
             the fifth day of January, two thousand and ten

                                 An Act

 
To designate the facility of the United States Postal Service located at 
 43 Maple Avenue in Shrewsbury, Massachusetts, as the ``Ann Marie Blute 
                             Post Office''.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,
SECTION 1. ANN MARIE BLUTE POST OFFICE.
    (a) Designation.--The facility of the United States Postal Service 
located at 43 Maple Avenue in Shrewsbury, Massachusetts, shall be known 
and designated as the ``Ann Marie Blute Post Office''.
    (b) References.--Any reference in a law, map, regulation, document, 
paper, or other record of the United States to the facility referred to 
in subsection (a) shall be deemed to be a reference to the ``Ann Marie 
Blute Post Office''.

                               Speaker of the House of Representatives.

                            Vice President of the United States and    
                                               President of the Senate.
```
<partyblock><br><br><div align="center"><b><font size="+1">Medical Diversified Services, Inc., as Assignee of William Tarplain, Respondent,<br><br>against<br><br>MVAIC, Appellant.</font></b></div><br><br><p>Morris, Duffy, Alonso &amp; Faley (Gregory S. Nelson, Esq.), for appellant.Lewin, Goodman, Baglio, LLP, for respondent (no brief filed).</p><p>Appeal from a judgment of the Civil Court of the City of New York, Queens County (Rudolph E. Greco, J.), entered September 12, 2014. The judgment, entered pursuant to a decision of the same court dated February 4, 2009, after a nonjury trial, awarded plaintiff the principal sum of $783.70.</p><p>ORDERED that, on the court's own motion, the notice of appeal from the decision dated February 4, 2009 is deemed a premature notice of appeal from the judgment entered September 12, 2014 (<i>see</i> CPLR 5520 [c]); and it is further,</p><p>ORDERED that the judgment is reversed, with $30 costs, and the matter is remitted to the Civil Court for the entry of a judgment in favor of defendant dismissing the complaint.</p><p>At a nonjury trial in this action by a provider to recover assigned first-party no-fault benefits, plaintiff's witness testified that the claims had been mailed to defendant Motor Vehicle Accident Indemnification Corporation (sued herein as MVAIC). Following the trial, the Civil Court awarded judgment to plaintiff in the principal sum of $783.70.</p><p>"The filing of a timely affidavit providing the MVAIC with notice of intention to file a claim is  a condition precedent to the right to apply for payment from [MVAIC].' Compliance with the statutory requirement of timely filing a notice of claim must be established in order to demonstrate that the claimant is a  covered person,' within the meaning of the statute, entitled to <font color="FF0000">[*2]</font>recover no-fault benefits from the MVAIC" (<a href="../2016/2016_51535.htm" target="_blank"><i>Avicenna Med. Arts, P.L.L.C. v MVAIC</i>, 53 Misc 3d 142</a>[A], 2016 NY Slip Op 51535[U], *1 [App Term, 2d Dept, 2d, 11th &amp; 13th Jud Dists 2016] [citations omitted]; <i>see</i> Insurance Law §§ 5208 [a] [1], [3]; 5221 [b] [2]). As plaintiff did not establish that such an affidavit had been submitted to MVAIC, plaintiff failed to establish its prima facie case (<i>see</i> Insurance Law §§ 5202 [b]; 5208, 5221 [b] [2]). </p><p>Accordingly, the judgment is reversed and the matter is remitted to the Civil Court for the entry of a judgment in favor of defendant dismissing the complaint.</p><p>PESCE, P.J., ALIOTTA and SOLOMON, JJ., concur.</p><br>ENTER:<br>Paul Kenny<br>Chief Clerk<br>Decision Date: December 22, 2017<br><br><div align="center"><form method="LINK" action="../../slipidx/at_2_idxtable.shtml"><input type="submit" value="Return to Decision List"></form></div></partyblock>
```

[Congressional Bills 111th Congress]
[From the U.S. Government Publishing Office]
[H.R. 4057 Introduced in House (IH)]

111th CONGRESS
  1st Session
                                H. R. 4057

   To amend the Wool Suit and Textile Trade Extension Act of 2004 to 
provide for certain payments from the Wool Apparel Manufacturers Trust 
                     Fund, and for other purposes.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                            November 6, 2009

Ms. Slaughter introduced the following bill; which was referred to the 
                      Committee on Ways and Means

_______________________________________________________________________

                                 A BILL

 
   To amend the Wool Suit and Textile Trade Extension Act of 2004 to 
provide for certain payments from the Wool Apparel Manufacturers Trust 
                     Fund, and for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. CERTAIN PAYMENTS FROM THE WOOL APPAREL MANUFACTURERS TRUST 
              FUND.

    (a) In General.--Section 4002(c)(3) of the Wool Suit and Textile 
Trade Extension Act of 2004 (Public Law 108-429; 7 U.S.C. 7101 note) is 
amended--
            (1) in the matter preceding subparagraph (A)--
                    (A) by striking ``From amounts'' and inserting 
                ``Except as provided in subparagraph (D), from 
                amounts''; and
                    (B) by striking ``2 additional'' and inserting 
                ``additional''; and
            (2) by adding at the end the following new subparagraph:
                    ``(D) During any calendar year in which a payment 
                may otherwise by payable, if a manufacturer provides to 
                the Bureau of Customs and Border Protection an 
                affidavit on or after October 1 of the immediately 
                preceding calendar year and on or before February 1 of 
                the such calendar year in which a payment may otherwise 
                be payable stating that such manufacturer remains a 
                manufacturer in the United States as of the date of 
                such affidavit, the Bureau shall make such payment not 
                later than 14 days after receipt of such affidavit or 
                as soon as is practicable, whichever is earlier.''.
    (b) Effective Date.--The amendment made by subsection (a) shall 
take effect and apply to affidavits filed on or after October 1, 2009.
                                 <all>
```
# Официален вестник C 212A/2019

| | ISSN 1977-0855 |
| --- | --- |
| Официален вестник
  на Европейския съюз | C 212A |
| | |
| Издание на български език | Информация и известия | Година 6224 юни 2019 г. |

ISSN 1977-0855

Официален вестник

на Европейския съюз

C 212A

Издание на български език

Информация и известия

Година 6224 юни 2019 г.

---

| Съдържание | Страница |
| --- | --- |
| | Поправки |
| 2019/C 212 A/01 | Поправка на Обява за свободно работно място за длъжността изпълнителен директор на Европейската агенция по лекарствата (ЕМА) — Амстердам (срочно нает служител — степен AD 14) — COM/2019/20037 ( ОВ С 165 А, 14.5.2019 г. ) | 1 |

Съдържание

Страница

Поправки

2019/C 212 A/01

Поправка на Обява за свободно работно място за длъжността изпълнителен директор на Европейската агенция по лекарствата (ЕМА) — Амстердам (срочно нает служител — степен AD 14) — COM/2019/20037 ( ОВ С 165 А, 14.5.2019 г. )

1

---

| BG | |
| --- | --- |

BG

---

Поправки

| 24.6.2019 | BG | Официален вестник на Европейския съюз | CA 212/1 |
| --- | --- | --- | --- |

24.6.2019

BG

Официален вестник на Европейския съюз

CA 212/1

---

Поправка на Обява за свободно работно място за длъжността изпълнителен директор на Европейската агенция по лекарствата (ЕМА) — Амстердам (срочно нает служител — степен AD 14) — COM/2019/20037

(
  Официален вестник на Европейския съюз С 165 А от 14 май 2019 г.
  )

(2019/C 212 A/01)

На страница 6, след „Краен срок“

вместо:

„Крайният срок за регистрация е 13 юни 2019 г. в 12,00 ч. на обяд брюкселско време, след което регистрацията повече няма да бъде възможна.“

да се чете:

да се чете

„Крайният срок за регистрация е 4 юли 2019 г. в 12,00 ч. на обяд брюкселско време, след което регистрацията повече няма да бъде възможна.“

---
II 

Calendar No. 393 

111TH CONGRESS 

2D SESSION H. R. 4238 

IN THE SENATE OF THE UNITED STATES 

FEBRUARY 23, 2010 

Received; read twice and referred to the Committee on Homeland Security and 

Governmental Affairs 

MAY 18, 2010 

Reported by Mr. LIEBERMAN, without amendment 

AN ACT 

To designate the facility of the United States Postal Service 

located at 930 39th Avenue in Greeley, Colorado, as 

the ‘‘W.D. Farr Post Office Building’’. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. W.D. FARR POST OFFICE BUILDING. 

4 (a) DESIGNATION.—The facility of the United States 

5 Postal Service located at 930 39th Avenue in Greeley, Col6 orado, shall be known and designated as the ‘‘W.D. Farr 

7 Post Office Building’’. 


PWALKER on DSK8KYBLC1PROD with BILLS
2 

•HR 4238 RS

1 (b) REFERENCES.—Any reference in a law, map, reg2 ulation, document, paper, or other record of the United 

3 States to the facility referred to in subsection (a) shall 

4 be deemed to be a reference to the ‘‘W.D. Farr Post Office 

5 Building’’. 


PWALKER on DSK8KYBLC1PROD with BILLS

PWALKER on DSK8KYBLC1PROD with BILLS
Calendar No. 393 

111TH CONGRESS 

2D SESSION H. R. 4238 

AN ACT 

To designate the facility of the United States Posting’’. Colorado, as the ‘‘W.D. Farr Post Office Build- al Service located at 930 39th Avenue in Greeley, 

MAY 18, 2010 

Reported without amendment 


PWALKER on DSK8KYBLC1PROD with BILLS
EXHIBIT 32.1

                Certification pursuant to 18 U.S.C. Section 1350,
      as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

     In connection with the Form 10-KSB/A of Absolute Potential, Inc. (the
"Company") for the year ended September 30, 2004, as filed with the Securities
and Exchange Commission on the date hereof (the "Report"), the undersigned
certifies, pursuant to 18 U.S.C. ss. 1350, as adopted pursuant to ss. 906 of the
Sarbanes-Oxley Act of 2002, to the best of their knowledge and belief, that:

          1)   the Report fully complies with the requirements of Sections 13(a)
               or 15(d) of the Securities and Exchange Act of 1934, as amended;
               and

          2)   the information contained in the Report fairly presents, in all
               material respects, the financial condition and results of
               operations of the Company.



                                            /s/  Thomas F. Duszynski
                                            -----------------------------------
                                                 Thomas F. Duszynski
                                                 Chief Executive Officer
                                                 Chief Financial Officer

                                            March 20, 2007

     This certification shall not be deemed "filed" for purposes of Section 18
of the Securities and Exchange Act of 1934, or the Exchange Act, or otherwise
subject to the liability of Section 18 of the Exchange Act. Such certification
shall not be deemed to be incorporated by reference into any filing under the
Securities Act of 1933 or the Exchange Act, except to the extent that the
Company specifically incorporates it by reference.
EXHIBIT - 31.1
SITEWORKS, INC.
CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER
I, Carl Nurse, certify that:
1.     I have reviewed this quarterly report on Form10-QSB/A of SiteWorks, Inc.;
2.     Based on my knowledge, this report does notcontain any untrue statement of a material fact or omit to state a material factnecessary to make the statements made, in light of the circumstances under whichsuch statements were made, not misleading with respect to the period covered bythis report.
3.     Based on my knowledge, the financial statements,and other financial information included in this report, fairly present in allmaterial respects the financial condition, results of operations and cash flowsof the registrant as of, and for, the periods presented in this report;
4.     The registrant’s other certifying officerand I are responsible for establishing and maintaining disclosure controls andprocedures (as defined in Exchange Act Rules 13a-15(e)(4) and 15d-15(e)(4)) forthe registrant and have:

(a)     designed suchdisclosure controls and procedures, or caused such disclosure controls andprocedures to be designed under our supervision, to ensure that materialinformation relating to the registrant, including its consolidated subsidiaries,is made known to us by others within those entities, particularly during theperiod in which this report is being prepared;

(b)     evaluated theeffectiveness of the registrant’s disclosure controls and procedures andpresented in this report our conclusions about the effectiveness of thedisclosure controls and procedures, as of the end of the period covered by thisreport based on such evaluation; and

(c)     disclosed in thisreport any change in the registrant’s internal control over financialreporting that occurred during the registrant’s most recent fiscal quarter(the registrant’s fourth fiscal quarter in the case of an annual report)that has materially affected, or is reasonably likely to materially affect theregistrant’s internal control over financial reporting;

5.     The registrant’s other certifying officerand I have disclosed, based on our most recent evaluation of internal controlover financial reporting, to the registrant’s auditors and the auditcommittee of the registrant’s board of directors  (or persons performingthe equivalent functions):

(a)     all significantdeficiencies and material weaknesses in the design or operation of internalcontrol over financial reporting which are reasonably likely to adversely affectthe registrant’s ability to record, process, summarize and reportfinancial information; and

(b)     any fraud, whether ornot material, that involves management or other employees who have a significantrole in the registrant’s internal control over financial reporting.

DATED:  January 12, 2005
/s/ CarlNurse                      Chairmanand Chief Executive Officer
<PAGE>

                                                                    EXHIBIT 21.1
                        HIGHLANDS INSURANCE GROUP, INC.

                              LIST OF SUBSIDIARIES

<TABLE>
<CAPTION>
                                               JURISDICTION OF INCORPORATION OR
NAME                                                     ORGANIZATION
----                                           --------------------------------
<S>                                            <C>
Aberdeen Insurance Company                      Texas
Highlands Casualty Company                      Texas
Highlands Claims and Safety Services, Inc.      Texas
Highlands Holdings (UK), Ltd.                   United Kingdom
Highlands Insurance Company (U.K.) Limited      United Kingdom
Highlands Insurance Company                     Texas
Highlands Limited                               Bermuda
Highlands Lloyds                                Texas
Highlands Overseas Limited                      Panama
Highlands Underwriters Insurance Company        Texas
Highlands Underwriters Insurance Agency, Inc.   Texas
Highlands Underwriting Agents, Limited          United Kingdom
Underwriters Special Risks of La., Inc.         Louisiana
Underwriters Special Risks, Inc.                Texas
American Professionals Insurance Company        Indiana
LMI Insurance Company                           Ohio
NN Insurance Company                            Wisconsin
Northwestern National Casualty Company          Wisconsin
Northwestern National Holding Company, Inc.     Delaware
Pacific Automobile Insurance Company            California
Pacific National Insurance Company              California
State Capital Insurance Company                 North Carolina
Statesman Insurance Company                     Indiana
American Reliance, Inc.                         Indiana
American Reliance Realty, Inc.                  Delaware
Lumbermens Financial Corporation                Ohio
Interstate Business Services, Inc.              Ohio
Interstate Insurance Agency, Inc. (Ohio)        Ohio
Certified Finance Corporation                   Texas
Insurance Management Corporation                Texas
SICO, Inc.                                      Indiana
Timeco, Inc.                                    Indiana
</TABLE>
EXHIBIT 32.0
 Section 1350 CERTIFICATION
   (1)
    
    The Quarterly Report on Form 10-Q of the Company for the fiscal quarter ended June 30, 2010
(the Report) fully complies with the requirements of Section 13(a) or 15(d) of the
Securities Exchange Act of 1934 (15 U.S.C. 78m(a) or 78o(d)); and
 (2)
    
    The information contained in the Report fairly presents, in all material respects, the
financial condition and results of operations of the Company.
 By:
    /s/ Ronald B. GeibRonald B. GeibChief Executive OfficerBy:
    /s/ Brendan J. McGillBrendan J. McGillExecutive Vice President, Chief
Operating and Financial Officer  Note:
    
    A signed original of this written statement required by Section 906 of the Sarbanes-Oxley Act has been provided to
Harleysville Savings Financial Corporation and will be retained by Harleysville Savings Financial Corporation and
furnished to the Securities and Exchange Commission or its staff upon request.